GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we handle diabetes mellitus . These new therapies help mimicking the body’s inherent GLP-1 process, https://keybookmarks.com/story21722529/glp-1-a-major-breakthrough-in-diabetes-treatment